Bessemer Group’s CareDx CDNA Stock Holding History

Bessemer Group’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-38	Closed	-$1K	–	2506
2025 Q2	$1K	Hold	38	–	–	﹤0.01%	2280
2025 Q1	$1K	Buy	+38	New	+$818	﹤0.01%	2319
2024 Q4	–	Sell	-45	Closed	-$1K	–	2484
2024 Q3	$1K	Buy	+45	New	+$1.12K	﹤0.01%	2360
2021 Q4	–	Sell	-168	Closed	-$11K	–	1865
2021 Q3	$11K	Buy	+168	New	+$12.8K	﹤0.01%	1349

Other funds holding CDNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OAM

Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Bessemer Group's CDNA Position: Q3 2025 in Review

Bessemer Group sold out of CareDx (CDNA) in Q3 2025, closing a stake of 38 shares — an estimated $1K sold.

Bessemer Group first reported a position in CDNA in Q3 2021 and held it in 4 quarters. The position peaked at $11K in Q3 2021. 187 funds tracked by Wall St. Rank hold CDNA as of Q3 2025.

Bessemer Group reported no remaining CareDx position as of Q3 2025 after selling out during the quarter.
Bessemer Group sold 38 CareDx shares in Q3 2025, an estimated $1K.
Bessemer Group first reported a position in CareDx in Q3 2021 and held it in 4 quarters.
Bessemer Group's CareDx position peaked at $11K in Q3 2021.
187 funds tracked by Wall St. Rank held CareDx as of Q3 2025.

Based on Bessemer Group's 13F filing for Q3 2025, filed 5 Nov 2025.